Possible role of the gut microbiome in mediating the beneficial effects of the six-herbal formulation STW 5-II on digestive health.

[1]  O. Kelber,et al.  Gut Microbiome–Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders , 2023, ACS chemical neuroscience.

[2]  S. Klauck,et al.  Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management , 2022, Pharmaceuticals.

[3]  Caode Jiang,et al.  Anti-inflammation of isoliquiritigenin via the inhibition of NF-κB and MAPK in LPS-stimulated MAC-T cells , 2022, BMC Veterinary Research.

[4]  S. Klauck,et al.  Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[5]  O. Kelber,et al.  Effects of the herbal preparation STW 5‐II on in vitro muscle activity in the guinea pig stomach , 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[6]  K. Verbeke,et al.  Short chain fatty acids in human gut and metabolic health. , 2020, Beneficial microbes.

[7]  R. Bauer,et al.  Application of an in vitro digestion model to study the metabolic profile changes of an herbal extract combination by UHPLC-HRMS. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[8]  S. A. Jacob,et al.  Prebiotic potential of polyphenols, its effect on gut microbiota and anthropometric/clinical markers: A systematic review of randomised controlled trials , 2020, Trends in Food Science & Technology.

[9]  Cheng Peng,et al.  Gut microbiota, a new frontier to understand traditional Chinese medicines , 2019, Pharmacological research.

[10]  K. Venema,et al.  Gut microbial metabolites in obesity, NAFLD and T2DM , 2019, Nature Reviews Endocrinology.

[11]  Ru Yan,et al.  Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing β-glucuronidase from Staphylococcus pasteuri 3I10 , 2018, Applied Microbiology and Biotechnology.

[12]  Jian Ji,et al.  Software Tools and Approaches for Compound Identification of LC-MS/MS Data in Metabolomics , 2018, Metabolites.

[13]  M. Marzorati,et al.  Arabinoxylo-Oligosaccharides and Inulin Impact Inter-Individual Variation on Microbial Metabolism and Composition, Which Immunomodulates Human Cells. , 2018, Journal of agricultural and food chemistry.

[14]  S. Duncan,et al.  Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics , 2017, The ISME Journal.

[15]  T. Efferth,et al.  Anti-inflammatory Effects of Herbal Preparations STW5 and STW5-II in Cytokine-Challenged Normal Human Colon Cells , 2016, Front. Pharmacol..

[16]  J. F. Stevens,et al.  The chemistry of gut microbial metabolism of polyphenols , 2016, Phytochemistry Reviews.

[17]  Y. Liu,et al.  The Pharmacological Activities of Licorice , 2015, Planta Medica.

[18]  C. Manichanh,et al.  Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome , 2015, Scientific Reports.

[19]  S. Raimondi,et al.  In vitro transformation of chlorogenic acid by human gut microbiota. , 2014, Molecular nutrition & food research.

[20]  D. Laukens,et al.  A dried yeast fermentate selectively modulates both the luminal and mucosal gut microbiota and protects against inflammation, as studied in an integrated in vitro approach. , 2013, Journal of agricultural and food chemistry.

[21]  P. van den Abbeele,et al.  Experimental models of the gut microbiome. , 2013, Best practice & research. Clinical gastroenterology.

[22]  F. Song,et al.  AN INVESTIGATION OF THE METABOLISM OF LIQUIRITIN AND THE IMMUNOLOGICAL EFFECTS OF ITS METABOLITES , 2012 .

[23]  C. Edwards,et al.  Colonic Catabolism of Ellagitannins, Ellagic Acid, and Raspberry Anthocyanins: In Vivo and In Vitro Studies , 2011, Drug Metabolism and Disposition.

[24]  M. Hattori,et al.  Bifidobacteria can protect from enteropathogenic infection through production of acetate , 2011, Nature.

[25]  W. Verstraete,et al.  Human faecal microbiota display variable patterns of glycerol metabolism. , 2010, FEMS microbiology ecology.

[26]  N. Moore,et al.  Antispasmodic and antioxidant activities of fractions and bioactive constituent davidigenin isolated from Mascarenhasia arborescens. , 2010, Journal of ethnopharmacology.

[27]  R. Lamuela-Raventós,et al.  Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells , 2009, British Journal of Nutrition.

[28]  C. Cordes,et al.  Pharmaceutical prerequisites for a multi-target therapy. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[29]  E. Levy,et al.  Short-chain fatty acids: ready for prime time? , 2006, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[30]  S. Walsh,et al.  Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial , 2005, Gut.

[31]  Y. Konishi,et al.  Microbial metabolites of ingested caffeic acid are absorbed by the monocarboxylic acid transporter (MCT) in intestinal Caco-2 cell monolayers. , 2004, Journal of agricultural and food chemistry.

[32]  W. Verstraete,et al.  PCR-DGGE-based quantification of stability of the microbial community in a simulator of the human intestinal microbial ecosystem. , 2004, FEMS microbiology ecology.

[33]  G. Holtmann,et al.  Treatment of Functional Dyspepsia with a Herbal Preparation , 2004, Digestion.

[34]  G. Holtmann,et al.  Treatment of irritable bowel syndrome with herbal preparations: results of a double‐blind, randomized, placebo‐controlled, multi‐centre trial , 2004, Alimentary pharmacology & therapeutics.

[35]  M. Aburada,et al.  Permeability of the flavonoids liquiritigenin and its glycosides in licorice roots and davidigenin, a hydrogenated metabolite of liquiritigenin, using human intestinal cell line Caco-2. , 2003, Journal of ethnopharmacology.

[36]  W. Verstraete,et al.  Bioaugmentation as a Tool To Protect the Structure and Function of an Activated-Sludge Microbial Community against a 3-Chloroaniline Shock Load , 2003, Applied and Environmental Microbiology.

[37]  I. Sassin,et al.  A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. , 2002, Zeitschrift fur Gastroenterologie.

[38]  G. Williamson,et al.  Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid , 2001, Journal of applied microbiology.

[39]  T. Kimura,et al.  Gastrointestinal absorption characteristics of glycyrrhizin from glycyrrhiza extract. , 1995, Biological & pharmaceutical bulletin.

[40]  G. Reglero,et al.  The gastrointestinal behavior of saponins and its significance for their bioavailability and bioactivities , 2018 .

[41]  Teruaki Akao,et al.  Isoliquiritigenin, one of the antispasmodic principles of Glycyrrhiza ularensis roots, acts in the lower part of intestine. , 2007, Biological & pharmaceutical bulletin.